Andere talen Nanjing Vazyme Biotech Co.,Ltd

Aandelen

688105

CNE100004ZK3

slotkoers Shanghai S.E. Andere beurzen 00:00:00 17-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
24,63 ^CNY	-1,20%		-12,94%	-23,08%

26/04	Nanjing Vazyme Biotech Co.,Ltd rapporteert resultaten voor het eerste kwartaal eindigend op 31 maart 2024	CI
15/04	Chinese aandelen stijgen na nieuwe richtlijnen; HK-aandelen dalen	RE

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Nanjing Vazyme Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
Nanjing Vazyme Biotech Unit Gets Nod to Register Six Medical Devices; Shares Slump 14%	15/04
China stocks rise after new guidelines; HK shares drop	15/04
Nanjing Vazyme Biotech Swings to Loss in 2023	29/02
Nanjing Vazyme Biotech Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Nanjing Vazyme Biotech Co.,Ltd announces an Equity Buyback for CNY 160 million worth of its shares.	06/02
Nanjing Vazyme Biotech Co., Ltd. authorizes a Buyback Plan.	05/02
Tranche Update on Nanjing Vazyme Biotech Co.,Ltd's Equity Buyback Plan announced on August 22, 2023.	24/11
Nanjing Vazyme Biotech Co.,Ltd's Equity Buyback announced on August 22, 2023, has closed with 618,077 shares, representing 0.15% for CNY 20.01 million.	24/11
Certain A Shares of Nanjing Vazyme Biotech Co., Ltd. are subject to a Lock-Up Agreement Ending on 15-NOV-2023.	15/11
Nanjing Vazyme Biotech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	27-10-23
Nanjing Vazyme Biotech Co.,Ltd(XSSC:688105) added to S&P Global BMI Index	18-09-23
Nanjing Vazyme Biotech Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	29-08-23
Nanjing Vazyme Biotech Plans Up to 30 Million Yuan Share Buyback	22-08-23
Nanjing Vazyme Biotech Co.,Ltd announces an Equity Buyback for CNY 30 million worth of its shares.	22-08-23
Nanjing Vazyme Biotech Co., Ltd. authorizes a Buyback Plan.	21-08-23
Nanjing Vazyme Biotech Co., Ltd.(SHSE:688105) added to Shanghai Stock Exchange Health Care Sector Index	12-06-23
Vazyme Signs Global Strategic Cooperation Agreement with Azenta	31-05-23
Vazyme Biotech Registers New Pneumonia Pathogen Detection Kit	23-05-23
Nanjing Vazyme Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26-04-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Nanjing Vazyme Biotech Co.,Ltd

Aandelen

688105

CNE100004ZK3

Andere talen

Filters